Serum biomarkers can predict a change in liver fibrosis 1 year after lifestyle intervention for biopsy-proven NASH.

Liver Int 2017 12 14;37(12):1887-1896. Epub 2017 Jun 14.

School of Medicine and Pharmacology, The University of Western Australia, Nedlands, Australia.

Background & Aims: The dynamic response of serum fibrosis biomarkers to histological changes within the liver following lifestyle intervention (LI) is unknown. We explored relationships between changes in serum biomarkers and liver fibrosis in NASH patients undergoing LI.

Methods: Paired liver biopsies were performed in 261 NASH patients to assess fibrosis change after 1 year of LI. We explored the utility of serum fibrosis markers to predict changes in hepatic fibrosis and developed and internally validated a model for predicting fibrosis improvement in patients with baseline fibrosis.

Results: Regression, stabilization and worsening of fibrosis occurred in 51 (20%), 165 (63%) and 45 (17%) patients respectively. By multivariable analysis, change in HbA1c (OR, 0.39, P<.01), platelets (OR, 1.22, P<.01) and NFS (OR, 0.27, P<.01), as well as ALT normalization (OR, 9.7, P<.01) were independently associated with fibrosis improvement, whereas change in platelets (OR, 0.96, P<.01), and NFS (OR, 1.8, P<.01) as well as ALT normalization (OR, 0.21, P<.01) were linked to fibrosis progression. A model, including change in HbA1c, platelet and ALT normalization, was significantly more accurate (AUC of 0.96, 95% CI, l0.94-0.99) than NFS, FIB-4 and APRI for predicting fibrosis improvement. Using a threshold of ≥0.497, positive and negative predictive values were 94% (95% CI, 84-98) and 91% (95% CI, 81-96) respectively.

Conclusions: Change in NFS, platelets and ALT normalization are associated with change in liver fibrosis after 1 year of LI. A model including change in HbA1c, platelet and ALT normalization discriminated patients with fibrosis improvement significantly better than other biomarkers.

Download full-text PDF

Source
http://dx.doi.org/10.1111/liv.13480DOI Listing
December 2017
29 Reads

Publication Analysis

Top Keywords

fibrosis
8
liver fibrosis
8
nash patients
8
lifestyle intervention
8
serum fibrosis
8
serum biomarkers
8
utility serum
4
explored utility
4
1 year explored
4
fibrosis markers
4
predict changes
4
fibrosis developed
4
hepatic fibrosis
4
changes hepatic
4
change 1 year
4
markers predict
4
assess fibrosis
4
liver biopsies
4
paired liver
4
limethods paired
4

References

(Supplied by CrossRef)
Liver biopsy
Rockey et al.
Hepatology 2009
Non-invasive tests for evaluation of liver disease severity and prognosis
EASL-ALEH Clinical Practice Guidelines et al.
J Hepatol 2015
Noninvasive evaluation of NAFLD
Castera et al.
Nat Rev Gastroenterol Hepatol 2013

Similar Publications